JP2024521419A5 - - Google Patents

Info

Publication number
JP2024521419A5
JP2024521419A5 JP2023575845A JP2023575845A JP2024521419A5 JP 2024521419 A5 JP2024521419 A5 JP 2024521419A5 JP 2023575845 A JP2023575845 A JP 2023575845A JP 2023575845 A JP2023575845 A JP 2023575845A JP 2024521419 A5 JP2024521419 A5 JP 2024521419A5
Authority
JP
Japan
Prior art keywords
filed
provisional application
government support
government
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023575845A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024521419A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/033037 external-priority patent/WO2022261455A2/en
Publication of JP2024521419A publication Critical patent/JP2024521419A/ja
Publication of JP2024521419A5 publication Critical patent/JP2024521419A5/ja
Pending legal-status Critical Current

Links

JP2023575845A 2021-06-11 2022-06-10 予防薬及び治療剤としての遺伝子改変されたSaccharomyces酵母株 Pending JP2024521419A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163209651P 2021-06-11 2021-06-11
US63/209,651 2021-06-11
US202263299693P 2022-01-14 2022-01-14
US63/299,693 2022-01-14
US202263317385P 2022-03-07 2022-03-07
US63/317,385 2022-03-07
PCT/US2022/033037 WO2022261455A2 (en) 2021-06-11 2022-06-10 Genetically-modified saccharomyces yeast strains as preventative and therapeutic agents

Publications (2)

Publication Number Publication Date
JP2024521419A JP2024521419A (ja) 2024-05-31
JP2024521419A5 true JP2024521419A5 (https=) 2025-07-23

Family

ID=82611116

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023575845A Pending JP2024521419A (ja) 2021-06-11 2022-06-10 予防薬及び治療剤としての遺伝子改変されたSaccharomyces酵母株

Country Status (5)

Country Link
US (1) US20240271082A1 (https=)
EP (1) EP4351731A2 (https=)
JP (1) JP2024521419A (https=)
CA (1) CA3221887A1 (https=)
WO (1) WO2022261455A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023064638A2 (en) * 2021-10-15 2023-04-20 The Trustees Of Columbia University In The City Of New York Compositions and methods for treating skin conditions
CN121532414A (zh) * 2023-05-18 2026-02-13 弗扎图赫股份有限公司 酵母平台

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US9963510B2 (en) 2005-04-15 2018-05-08 Macrogenics, Inc. Covalent diabodies and uses thereof
ES2971647T3 (es) 2005-04-15 2024-06-06 Macrogenics Inc Diacuerpos covalentes y usos de los mismos
US20070161031A1 (en) 2005-12-16 2007-07-12 The Board Of Trustees Of The Leland Stanford Junior University Functional arrays for high throughput characterization of gene expression regulatory elements
JP7184336B2 (ja) * 2015-10-13 2022-12-06 ザ ユニバーシティ オブ メリーランド,ボルチモア クロストリジウム・ディフィシル感染症に対する酵母ベースの免疫療法

Similar Documents

Publication Publication Date Title
JP2024521419A5 (https=)
JP2024116190A5 (https=)
JP2021524958A5 (https=)
JP2023134519A5 (https=)
JP2025176106A5 (https=)
JP2022538004A5 (https=)
CN115943162A (zh) 抗Claudin18.2抗体以及其用途
JP2017176174A5 (https=)
CN114650845A (zh) 抗密蛋白抗体药物偶联物及其医药用途
JP2025098156A5 (https=)
JP2023154065A5 (https=)
CN114945595A (zh) 抗lag3单克隆抗体及其制备方法和应用
JP2025090801A5 (https=)
JP2024149687A5 (https=)
JP2021527039A5 (https=)
JP2023156274A5 (https=)
JP2024156672A5 (https=)
JP2026010057A5 (https=)
JP2024059782A5 (https=)
JP2024515418A5 (https=)
JP2023013438A5 (https=)
JP2024532851A5 (https=)
JPWO2023119866A5 (https=)
JP2023521031A5 (https=)
JPWO2021025047A5 (https=)